Symposium delegates will have the opportunity to shape the future of post-TB care in daily, interactive Design Labs. By uniting scientific expertise with advocacy and lived experiences, these small-group sessions will focus on building practical solutions to challenges facing the post-TB community. You will work alongside global peers to turn collective insights into actionable strategies that elevate survivor well-being.

Proposed Design Lab Modules, their goals, and the concrete outputs that would come from these Design Labs, are described

here:

●      End-of-Treatment Morbidity Assessment Tool

Brief description: To develop a pragmatic, feasible end-of-treatment morbidity assessment tool/indicator set that could be used in 5-minutes or less in TB facilities and by NTPs globally. 

Output: Draft tool to assess morbidity at the end of TB treatment

●      Post-TB Educational Pamphlets 

Brief description: To develop 3 sets of post-TB pamphlets with educational/awareness material for (1) survivors, (2) clinicians, program staff, (3) community, stakeholders addressing what we think each group should know about post-TB sequelae and life, including how to reduce stigma.  

Output: 3 pamphlets/infographics

●      Setting Advocacy Priorities for Post-TB

Brief description: To co-create an actionable roadmap with key advocacy priorities at local, national, and global levels.

Output: Brief with key advocacy priorities

●    “TB and Me”: Survivor Experiences

Brief description: To capture and describe the most important concerns, fears, and anxieties about the lived experience of TB at TB diagnosis, end-of-treatment, and post-TB.

Output: Document/infographic highlighting TB survivor stories

●      Post-TB Core Outcome Set for Trials  

Brief description: To develop a process and methodology for establishing a core outcome set for PTLD intervention trials covering physiological, functional, structural, and patient-reported endpoints.

Output: Roadmap and short-list for a PTLD core outcome set

●      Treatable Traits for Providers  

Brief description: Building upon work from the last symposium, identify clinically relevant Treatable Traits that can be managed by TB and primary health care providers.

Output: Infographic/PDF for use in clinical settings

●      Translating Biomarkers for Prediction and Host-Directed Therapies

Brief description: To explore how the biological pathways that persist after TB treatment can be translated into biomarkers, host-directed therapies, and more targeted post-TB care.

Output: Roadmap with prioritized biological pathways for monitoring in clinical studies and trials